| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.0074 | 0.9 |
| mRNA | CIL55A | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | PD 153035 | CTRPv2 | pan-cancer | AAC | 0.0056 | 0.9 |
| mRNA | MK-0752 | CTRPv2 | pan-cancer | AAC | 0.0052 | 0.9 |
| mRNA | tamatinib | CTRPv2 | pan-cancer | AAC | -0.0051 | 0.9 |
| mRNA | fingolimod | CTRPv2 | pan-cancer | AAC | -0.0048 | 0.9 |
| mRNA | SNS-032 | CTRPv2 | pan-cancer | AAC | 0.0048 | 0.9 |
| mRNA | Vorinostat | CTRPv2 | pan-cancer | AAC | 0.0044 | 0.9 |
| mRNA | vorapaxar | CTRPv2 | pan-cancer | AAC | -0.005 | 0.9 |